Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Apogee Therapeutics, Inc. Financials Banner

Apogee Therapeutics, Inc. Financials

APGE Stock Analysis

Page title

Section title

APGE Income Statement Key Metrics

  • Revenue(TTM)0
  • Gross Profit(TTM)-65,000
  • EBITDA(TTM)-140.23 M
  • Net Income(TTM)-118.49 M
  • EPS Diluted(TTM)-2.2800000000000002

Decode APGE's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

APGE earnings and revenue history

APGE Return on Equity

See how efficiently APGE generates profit for it's shareholders.

0%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity Growth

APGE's Return on Equity has grown significantly over the past 10 years, increasing by over 52.98%.

APGE Revenue Growth

See how APGE has grown it's revenue over the past 10 years.


Revenue Growth

APGE's revenue has shown poor growth over the past 10 years, increasing by only 0%.

APGE FY, 2023 Revenue Breakdown

See how APGE converts it's revenue into profit.

APGE Balance Sheet Health

APGE Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

APGE financial position analysis

Short Term Liabilities

APGE's short term assets($398M) can safely cover it's short term liabilities($21M).

Long Term Liabilities

APGE's short term assets($398M) can safely cover it's long term liabilities($933K).

APGE Debt to Equity